Intrauterine growth restriction: Screening, diagnosis, and management;Retard de croissance intra-utérin : Dépistage, Diagnostic et prise en charge

Journal of Obstetrics and Gynaecology Canada

Volumn 35, Issue 8, 2013, Pages 749-757

  Lausman, Andrea ^a   Kingdom, John ^a   Gagnon, Robert ^a   Basso, Melanie ^a   Bos, Hayley ^a   Crane, Joan ^b   Davies, Gregory ^a   Delisle, Marie France ^a   Hudon, Lynda ^a   Menticoglou, Savas ^a   Mundle, William ^a   Ouellet, Annie ^a   Pressey, Tracy ^a   Pylypjuk, Christy ^a   Roggensack, Anne ^a   Sanderson, Frank ^a  

^a NONE   (Canada)

^b St john's NL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DIAGNOSTIC TEST; INTRAUTERINE GROWTH RETARDATION; MEDICAL CARE; SCREENING TEST; CANADA; DIAGNOSIS; DISEASE MANAGEMENT; DOPPLER; FEMALE; FETUS ECHOGRAPHY; GESTATIONAL AGE; HUMAN; INTRAUTERINE GROWTH RESTRICTION (IUGR); LOW BIRTH WEIGHT; MANAGEMENT; MASS SCREENING; METHODOLOGY; NEWBORN; PERINATAL CARE; PLACENTA; PRACTICE GUIDELINE; PREGNANCY; RISK ASSESSMENT; RISK FACTOR; SCREENING; STANDARD; ULTRASOUND;

DIAGNOSIS; DOPPLER; INTRAUTERINE GROWTH RESTRICTION (IUGR); MANAGEMENT; PLACENTA; SCREENING; ULTRASOUND;

CANADA; DISEASE MANAGEMENT; FEMALE; FETAL GROWTH RETARDATION; GESTATIONAL AGE; HUMANS; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; MASS SCREENING; PERINATAL CARE; PREGNANCY; RISK ASSESSMENT; RISK FACTORS; ULTRASONOGRAPHY, PRENATAL;

EID: 84973879761     PISSN: 17012163     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1701-2163(15)30866-5     Document Type: Article

References (55)

1. Abdel-Fattah S.A., Bhat A., Illanes S., Bartha J.L., Carrington D. TORCH test for fetal medicine indications: only CMV is necessary in the United Kingdom. Prenat Diagn 2005, 25:102831.
2. Alfirevic Z., Neilson J.P. Doppler ultrasonography in high-risk pregnancies: systematic review with meta-analysis. Am J Obstet Gynecol 1995, 172:137987.
3. Alley M.H., Hadjiev A., Mazneikova V., Dimitrov A. Four-quadrant assessment of gestational age-specific values of amniotic fluid volume in uncomplicated pregnancies. Acta Obstet Gynecol Scand 1998, 77:2904.
4. American College of Obstetricians and Gynecologists Intrauterine Growth Restriction. ACOG Practice Bulletin No. 12 2000, ACOG, Washington DC.
5. Ayala D.E., Ucieda R., Hermida R.C. Chronotherapy with low-dose aspirin for prevention of complications in pregnancy. Chronobiol Int 2013, 30:26079. 10.3109/07420528.2012.717455.
6. Bamberg C., Kalache K.D. Prenatal diagnosis of fetal growth restriction. Semin Fetal Neonatal Med 2004, 9:38794.
7. Baschat A.A., Cosmi E., Bilardo C.M., Wolf H., Berg C., Rigano S., et al. Predictors of neonatal outcome in early-onset placental dysfunction. Obstet Gynecol 2007, 109(2 Pt 1):25361.
8. Becker R., Keller T., Kiesewetter H., Fangerau H., Bittner U. Individual risk assessment of adverse pregnancy outcome by multivariate regression analysis may serve as basis for drug intervention studies: retrospective analysis of 426 high-risk patients including ethical aspects. Arch Gynecol Obstet 2013, 288:418. 10.1007/s00404-013-2723-1.
9. Boers K.E., van Wyk L., van der Post J.A., Kwee A., van Pampus M.G., Spaanderdam M.E., et al. DIGITAT Study Group. Neonatal morbidity after induction vs expectant monitoring in intrauterine growth restriction at term: a subanalysis of the DIGITAT RCT. Am J Obstet Gynecol. 2012, 206:344.e1-344.e7. doi: 10.1016/j.ajog.2012.01.015.
10. Boers K.E., Vijgen S.M., Bijlenga D., van der Post J.A., Bekedam D.J., Kwee A., et al. Induction versus expectant monitoring for intrauterine growth restriction at term: randomised equivalence trial (DIGITAT). BMJ 2010, 341:c7087.
11. Brenner W.E., Edelman D.A., Hendricks C.H. A standard of fetal growth for the United States of America. Am J Obstet Gynecol 1976, 126:55564.
12. Bricker L., Neilson J.P. Routine Doppler ultrasound in pregnancy. Cochrane Database Syst Rev 2000, 2.
13. Bricker L., Neilson J.P., Dowswell T. Routine ultrasound in late pregnancy (after 24 weeks' gestation). Cochrane Database Syst Rev 2008, 4.
14. Bujold E., Roberge S., Lacasse Y., Bureau M., Audibert F., Marcoux S., et al. Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis. Obstet Gynecol 2010, 116(2 Pt 1):40214. 10.1097/AOG.0b013e3181e9322a.
15. Carberry A.E., Gordon A., Bond D.M., Hyett J., Raynes-Greenow C.H., Jeffery H.E. Customised versus population-based growth charts as a screening tool for detecting small for gestational age infants in low-risk pregnant women. Cochrane Database Syst Rev 2011, 12. Dec 7. 10.1002/14651858.CD008549.pub2.
16. Chauhan S.P., Magann E.F. Screening for fetal growth restriction. Clin Obstet Gynecol 2006, 49:28494.
17. Dayal A.K., Manning F.A., Berck D.J., Mussalli G.M., Avila C., Harman C.R., et al. Fetal death after normal biophysical profile score: an eighteen-year experience. Am J Obstet Gynecol 1999, 181(5 Pt 1):12316.
18. Dudley N.J. A systematic review of the ultrasound estimation of fetal weight. Ultrasound Obstet Gynecol 2005, 25:809.
19. Dugoff L. First- and second-trimester maternal serum markers for aneuploidy and adverse obstetric outcomes. Obstet Gynecol 2010, 115:1052-1061.
20. Dugoff L., Hobbins J.C., Malone F.D., Vidaver J., Sullivan L., Canick J.A., et al. Quad screen as a predictor of adverse pregnancy outcome. Obstet Gynecol 2005, 106(2):2607.
21. Figueras F., Gardosi J. Intrauterine growth restriction: new concepts in antenatal surveillance, diagnosis, and management. Am J Obstet Gynecol 2011, 204:288-300. 10.1016/j.ajog.2010.08.055.
22. Gardosi J. Customised assessment of fetal growth potential: implications for perinatal care. Arch Dis Child Fetal Neonatal Ed 2012, 97:F314-7. 10.1136/fetalneonatal-2012-301708.
23. Gardosi J., Chang A., Kalyan B., Sahota D., Symonds E.M. Customised antenatal growth charts. Lancet 1992, 339:2837.
24. Grivell R.M., Alfirevic Z., Gyte G.M., Devane D. Antenatal cardiotocography for fetal assessment. Cochrane Database Syst Rev 2010, 1.
25. Grivell R.M., Wong L., Bhatia V. Regimens of fetal surveillance for impaired fetal growth. Cochrane Database Syst Rev 2012, 6. Jun 13. 10.1002/14651858.CD007113.pub3.
26. Haram K., Softeland E., Bukowski R. Intrauterine growth restriction. Int J Gynaecol Obstet 2006, 93:512.
27. Konchak P.S., Bernstein I.M., Capeless E.L. Uterine artery Doppler velocimetry in the detection of adverse obstetric outcomes in women with unexplained elevated maternal serum alpha-fetoprotein levels. Am J Obstet Gynecol 1995, 173:11159.
28. Lackman F., Capewell V., Richardson B. daSilva O, Gagnon R. The risks of spontaneous preterm delivery and perinatal mortality in relation to size at birth according to fetal versus neonatal growth standards. Am J Obstet Gynecol 2001, 184(5):946-953.
29. Lausman A., McCarthy F.P., Walker M., Kingdom J. Screening, diagnosis, and management of intrauterine growth restriction. J Obstet Gynaecol Can 2012, 34:1728.
30. Lindhard A., Nielsen P.V., Mouritsen L.A., Zachariassen A., Sorensen H.U., Roseno H. The implications of introducing the symphyseal-fundal height-measurement. A prospective randomized controlled trial. Br J Obstet Gynaecol 1990, 97:67580.
31. Mari G., Hanif F., Kruger M., Cosmi E., Santolaya-Forgas J., Treadwell M.C. Middle cerebral artery peak systolic velocity: a new Doppler parameter in the assessment of growth-restricted fetuses. Ultrasound Obstet Gynecol 2007, 293:3106.
32. Maulik D. Fetal growth compromise: definitions, standards, and classification. Clin Obstet Gynecol 2006, 49:2148.
33. McCowan L.M., Dekker G.A., Chan E., Stewart A., Chappell L.C., Hunter M., et al. Spontaneous preterm birth and small for gestational age infants in women who stop smoking early in pregnancy: prospective cohort study. BMJ 2009, 338:b1081.
34. Mitani M., Matsuda Y., Makino Y., Akizawa Y., Ohta H. Clinical features of fetal growth restriction complicated later by preeclampsia. J Obstet Gynaecol Res 2009, 35:8827.
35. Neilson J.P. Symphysis-fundal height measurement in pregnancy. Cochrane Database Syst Rev 2000, 2.
36. Neilson J.P., Alfirevic Z. Doppler ultrasound for fetal assessment in high risk pregnancies. Cochrane Database Syst Rev 2000, 2.
37. Nyberg D.A., Abuhamad A., Ville Y. Ultrasound assessment of abnormal fetal growth. Semin Perinatol 2004, 28:322.
38. Pinar H., Carpenter M. Placenta and umbilical cord abnormalities seen with stillbirth. Clin Obstet Gynecol 2010, 53:65672.
39. Proctor L.K., Whittle W.L., Keating S., Viero S., Kingdom J.C. Pathologic basis of echogenic cystic lesions in the human placenta: role of ultrasound-guided wire localization. Placenta 2010, 31:11115.
40. Reeves S., Bernstein I. Effects of maternal tobacco-smoke exposure on fetal growth and neonatal size. Expert Rev Obstet Gynecol 2008, 3:71930.
41. Roberge S., Giguère Y., Villa P., Nicolaides K., Vainio M., Forest J.C., et al. Early administration of low-dose aspirin for the prevention of severe and mild preeclampsia: a systematic review and meta-analysis. Am J Perinatol 2012, 29:5516. 10.1055/s-0032-1310527.
42. Roberge S., Nicolaides K., Demers S., Villa P., Bujold E. Prevention of perinatal death and adverse perinatal outcome using low-dose aspirin: a meta-analysis. Ultrasound Obstet Gynecol 2013, 41:4919. 10.1002/uog.12421.
43. Roberge S., Villa P., Nicolaides K., Giguère Y., Vainio M., Bakthi A., et al. Early administration of low-dose aspirin for the prevention of preterm and term preeclampsia: a systematic review and meta-analysis. Fetal Diagn Ther 2012, 31:1416. 10.1159/000336662.
44. Robert Peter J, Ho JJ, Valliapan J, Sivasangari S. Symphysial fundal height (SFH) measurement in pregnancy for detecting abnormal fetal growth. Cochrane Database Syst Rev 2012 Jul 11;7:CD008136. doi: 10.1002/14651858.CD008136.pub2.
45. Roberts D., Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Sys Rev 2006, 3. Jul 19.
46. Royal College of Obstetricians The investigation and management of the small-for-gestational age fetus. Guideline No. 31 2002, ACOG, London.
47. Siddiqui N., Hladunewich M. Understanding the link between the placenta and future cardiovascular disease. Trends Cardiovasc Med 2011, 21:188-193. 10.1016/j.tcm.2012.05.008.
48. Simchen M.J., Alkazaleh F., Adamson S.L., Windrim R., Telford J., Beyene J., et al. The fetal cardiovascular response to antenatal steroids in severe early-onset intrauterine growth restriction. Am J Obstet Gynecol 2004, 190:296304.
49. Smith G.C., Smith M.F., McNay M.B., Fleming J.E. The relation between fetal abdominal circumference and birthweight: findings in 3512 pregnancies. Br J Obstet Gynaecol 1997, 104:18690.
50. Smith G.C., Yu C.K., Papageorghiou A.T., Cacho A.M., Nicolaides K.H. Maternal uterine artery Doppler flow velocimetry and the risk of stillbirth. Obstet Gynecol 2007, 109:14451.
51. Snijders R.J., Sherrod C., Gosden C.M., Nicolaides K.H. Fetal growth retardation: associated malformations and chromosomal abnormalities. Am J Obstet Gynecol 1993, 168:54755.
52. Toal M., Chaddha V., Windrim R., Kingdom J. Ultrasound detection of placental insufficiency in women with elevated second trimester serum alpha-fetoprotein or human chorionic gonadotropin. J Obstet Gynaecol Can 2008, 30:198206.
53. van Wyk L., Boers K.E., van der Post J.A., van Pampus M.G., van Wassenaer A.G., van Baar A.L., et al. DIGITAT Study Group. Effects on (neuro)developmental and behavioral outcome at 2 years of age of induced labor compared with expectant management in intrauterine growth-restricted infants: long-term outcomes of the DIGITAT trial. Am J Obstet Gynecol 2012, 206:406.e1-406.e7. doi: 10.1016/j.ajog.2012.02.003.
54. von Beckerath A.K., Kollmann M., Rotky-Fast C., Karpf E., Lang U., Klaritsch P. Perinatal complications and long-term neurodevelopmental outcome of infants with intrauterine growth restriction. Am J Obstet Gynecol 2013, 208:130.e1-130.e6. doi: 10.1016/j.ajog.2012.11.014.
55. Zhang J., Troendle J., Meikle S., Klebanoff M.A., Rayburn W.F. Isolated oligohydramnios is not associated with adverse perinatal outcomes. BJOG 2004, 111:2205.